Anton J. Oude Ophuis

High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary Syndrome.

R. D. de Winter, M. Simoons, P. van der Harst, 2019, Circulation.

Serially measured high-sensitivity cardiac troponin T, N-terminal-pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and growth differentiation factor 15 for risk assessment after acute coronary syndrome: the BIOMArCS cohort

Muhammed T. Gürgöze, R. D. de Winter, E. Boersma, 2023, European Heart Journal. Acute Cardiovascular Care.

Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study

P. Harst, H. Crijns, P. van der Harst, 2020, Clinical chemistry and laboratory medicine.

Temporal Evolution of Serum Concentrations of High‐Sensitivity Cardiac Troponin During 1 Year After Acute Coronary Syndrome Admission

R. D. de Winter, M. Simoons, P. van der Harst, 2020, Journal of the American Heart Association.

Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome—a prospective multicentre biomarker study conducted in the Netherlands

R. D. de Winter, R. J. Winter, P. Harst, 2016, BMJ Open.

Edoxaban versus Warfarin in Patients with Atrial Fibrillation in Relation to the Risk of Stroke: A Secondary Analysis of the ENGAGE AF-TIMI 48 Study.

E. Antman, R. Giugliano, S. Murphy, 2021, American heart journal.

Details on high frequency blood collection, data analysis, available material and patient characteristics in BIOMArCS

R. D. de Winter, P. van der Harst, E. Boersma, 2019, Data in brief.